Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06311617 · ClinicalTrials.gov registry record
Retinal Vascular Changes During Pregnancy
A clinical trial of Pregnancy, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT06311617: Recruiting study of Pregnancy, sponsored by Vanderbilt University Medical Center.
NCT06311617 is a study of Pregnancy that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 90 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06311617, a study of Pregnancy, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and after delivery. This imaging is non-invasive and does not require contact with the surface of the eye. The photos taken will allow assessment of specific parameters, like blood flow and the health of specialized cells that support vision. Understanding how the eyes change during pregnancy may help guide how retina specialists understanding of retinal disease during pregnancy and better inform pregnancy outcomes.
Primary Outcome
Choroidal thickness
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Optical coherence tomography
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2027-01 |
What NCT06311617 shows while recruiting
NCT06311617 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Optical coherence tomography is the first listed.
NCT06311617 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06311617 about?
NCT06311617 is a clinical study titled "Retinal Vascular Changes During Pregnancy". The goal of this study is to better understand how the back part of the eye-called the retina and the choroid-changes during pregnancy. Specialized photos of the eye will be taken at three different timepoints: early in pregnancy (first or second trimester), late in pregnancy (third trimester), and ...
What is the current status of trial NCT06311617?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2024-02-01. Estimated completion is 2027-01.
What conditions does trial NCT06311617 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT06311617?
The interventions under investigation include: Optical coherence tomography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06311617?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06311617 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06311617's enrollment target sits among peer trials
90 124th of 191 higher than 68 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI